Hormonal therapy of breast cancer

被引：48

作者：

Locker, GY ^{[1
]}

机构：

[1] Northwestern Univ, Evanston Northwestern Healthcare, Evanston, IL USA

来源：

CANCER TREATMENT REVIEWS | 1998年 / 24卷 / 03期

关键词：

D O I：

10.1016/S0305-7372(98)90051-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：221 / 240

页数：20

共 276 条

[1]

ABE O, 1992, LANCET, V339, P71

[2] THE USE OF ESTROGENS AND ANDROGENS IN ADVANCED MAMMARY CANCER - CLINICAL AND LABORATORY STUDY OF 105 FEMALE PATIENTS [J].

ADAIR, FE ;

MELLORS, RC ;

FARROW, JH ;

WOODARD, HQ ;

ESCHER, GC ;

URBAN, JA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1949, 140 (15) :1193-1200

[3]

ADAM HK, 1980, CANCER TREAT REP, V64, P761

[4]

ALBAIN K, 1997, P AN M AM SOC CLIN, V16, pA128

[5] PROGESTIN REGULATION OF ESTROGEN-RECEPTOR MESSENGER-RNA IN HUMAN BREAST-CANCER CELLS [J].

ALEXANDER, IE ;

SHINE, J ;

SUTHERLAND, RL .

MOLECULAR ENDOCRINOLOGY, 1990, 4 (06) :821-828

[6] RANDOMIZED TRIAL OF TAMOXIFEN VERSUS AMINOGLUTETHIMIDE AND VERSUS COMBINED TAMOXIFEN AND AMINOGLUTETHIMIDE IN ADVANCED POSTMENOPAUSAL BREAST-CANCER [J].

ALONSOMUNOZ, MC ;

OJEDAGONZALEZ, MB ;

BELTRANFABREGAT, M ;

DORCARIBUGENT, J ;

LOPEZLOPEZ, L ;

BORRASBALADA, J ;

CARDENALALEMANV, F ;

GOMEZBATISTE, X ;

FABREGATMAYOL, J ;

VILADIUQUEMADA, P .

ONCOLOGY, 1988, 45 (05) :350-353

[7]

[Anonymous], 1996, Lancet, V348, P1189

[8]

[Anonymous], 1986, J Clin Oncol, V4, P186

[9]

[Anonymous], 1988, NEW ENGL J MED, V319, P1681

[10]

[Anonymous], 1993, Lancet, V341, P1293

← 1 2 3 4 5 6 7 8 9 10 →